Background. HIV-associated encephalitis (HIVE) is one of the common complications of HIV infection, and the pathogenesis of HIVE remains unclear, while lncRNA might be involved it. In this study, we made re-annotation on the expression profiling from the HIVE study in the public database, identified the lncRNA that might be involved in HIVE, and explored the possible mechanism. Methods. In the GEO public database, the microarray expression profile (GSE35864) of three regions of brain tissues (white matter, frontal cortex and basal ganglia brain tissues) was chosen, updated annotation was performed to construct the noncording-RNA (ncRNA) microarray data. Morpheus was used to identify the differential expressed ncRNA, and Genbank of NCBI was used to identify lncRNAs. The StarBase, PITA and miRDB databases were used to predict the target miRNAs of lncRNA. The TargetScan, PicTar and MiRanda databases were used to predict the target genes of miRNAs. The GO and KEGG pathway analysis were used to make function analysis on the targets genes. Results. Seventeen differentially expressed lncRNAs were observed in the white matter of brain tissues, for which 352 target miRNAs and 6,659 target genes were predicted. The GO function analysis indicated that the lncRNAs were mainly involved in the nuclear transcription and translation processes. The KEGG pathway analysis showed that the target genes were significantly enriched in 33 signal pathways, of which 11 were clearly related to the nervous system function. Discussion. The brand-new and different microarray results can be obtained through the updated annotation of the chips, and it is feasible to identify lncRNAs from ordinary chips. The results suggest that lncRNA may be involved in the occurrence and development of HIVE, which provides a new direction for further research on the diagnosis and treatment of HIVE.
INTRODUCTION
Cognitive impairment is one of the challenges that HIV patients may face (Clifford & Ances, 2013) . HIV-1 enters the central nervous system through the blood-brain barrier at the initial infection stage, and a virus replicating area isolated from the body is formed in the central nervous system (Stam et al., 2013) . Before the introduction of highly active anti-retroviral therapy (HAART), many HIV patients would soon suffer severe cognitive impairment, which is called HIV associated dementia (HAD), patients with HAD usually suffer from HIV-associated encephalitis (HIVE) (Masliah et al., 2000) . Although HAART is very effective at present, HIV-induced brain inflammation has been frequently noticed in autopsy, and neurocognitive test results are abnormal in most HIV patients (Clifford & Ances, 2013) . Currently, HIV cannot be radically eradicated by any HIV therapy, and the anti-retroviral viruses can hardly pass the blood-brain barrier, so the central nervous system may become a virus repository that might promote the occurrence and development of HIVE (Kumar et al., 2007) . At present, the pathogenesis of HIVE is not very clear. Studying the molecular signaling pathways invovled in HIVE would be significance for the prevention and treatment of HIVE.
In the human genome, more than 70% of the genes are transcribed into RNAs, but less than 2% of them are protein coding genes, and most of them are noncoding RNAs (Costa, 2010) . Non-coding RNAs (ncRNAs) regulate the expression of targeted genes through various pathways, and thus participate in various life processes of cells, tissues and organisms. According to the length, ncRNAs can be divided into small ncRNAs (<200 bp) and long ncRNAs (lncRNAs) (>200 bp). In recent years, studies have found that there are interactions between RNAs of different lengths, especially the relationship between lncRNA, miRNA and mRNA, which form a regulatory network of lncRNA-miRNA-mRNA. LncRNAs could be the ''molecular sponges'' of miRNAs, that is, lncRNAs could bind to target miRNAs leading to the ''silencing effect'' attenuation of miRNAs on target genes, thereby regulating the target genes of miRNAs (Salmena et al., 2011) . This study is aiming to identify the lncRNA might be involved in HIVE from expression profile, and explore the possible mechanisms.
In recent years, expression microarray technology has played an important role in the research on the disease occurrence and development, and many research results can be reviewed and downloaded in the public database. Because updated annotation of microarray results has always been continuing, new results and novel revelation can be accomplished through the re-annotation and analysis of published studies on microarray results. In this study, we retrieved the HIVE study related microarray data from the GEO database, re-annotated and analyzed these data, identified the lncRNAs that might be involved in the pathogenesis of HIVE, and performed the correlation analysis (the work flow was shown in Fig. 1 ), aiming to verify the feasibility of identifying lncRNAs from expression profile from public database and to explore the possible mechanisms of lncRNAs participating in pathogenesis of HIVE. 
MATERIALS AND METHODS

Microarray data
The Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo), curated by the National Center for Biotechnology Information (NCBI), is a public functional genomics database, and the data could be downloaded for free. In the GEO database, the microarray expression profile (GSE35864) in three regions of the brain, basal ganglia, white matter, and frontal cortex, in normal, HIV infected, HIV infected with neurocognitive impairment, and HIV infected with both neurocognitive impairment and encephalitis patients was chosen. Twenty-four human subjects in four groups were examined: Group A (n = 6) HIV-1 uninfected with no neuropathological abnormalities at autopsy; Group B (n = 6) HIV-1-infected (HIV+) neuropsychologically normal with no neuropathology; Group C (n = 7) HIV+ with substantial HIV-associated neurocognitive impairment (HAND) as defined below, with no encephalitis (HIVE) or substantial neuropathological defect; Group D (n = 5) HIV+ with HAND and HIVE. RNA from neocortex, white matter, and neostriatum was processed with the Affymetrix Human Genome U133 Plus 2.0 Array platform.
Identifying differentially expressed lncRNAs
First, the latest annotation files of HG-U133_Plus_2 Annotations, CSV format, Release 36 (7/12/16) of the Affymetrix Human Genome U133 Plus 2.0 Array were downloaded from the website http://www.affymetrix.com/support/technical/annotationfilesmain.affx, including the probe set ID, gene symbol, gene title, ensemble gene ID, Refseq transcript ID and information related to the probe. The gene expression data of the chips corresponded to the probe ID, and meanwhile the probes were labeled with Refseq transcript ID through the NetAffx annotation. The probes with the ''NR_'' logo were identified in Refseq ID (NR representing nonencoding RNA). Morpheus (https://software.broadinstitute.org/morpheus/) was used to analyze online and identify the differential expressed ''NR_'' between the groups (Group A vs. Group D, Group B vs. Group D and Group C vs. Group D) of each region tissue (white matter, frontal cortex and basal ganglia brain tissues). This analysis was based on the t -test and adjusted according to the characteristic that the noise of microarray data was correlated with the peak value of expression data. We considered that p-value <0.01 was statistically significant. The number of upregulation and downregulation was 100). The Wayne map was drawn based on the intersection of the above results to select differential ''NR_'' participating in the occurrence and development of HIVE. The pseudogenes, rRNAs, microRNAs and other short RNAs (including tRNAs, snRNAs and snoRNAs) were filtered out through Genbank from NCBI database. The final remainder was the differential expressed lncRNAs.
Prediction of target miRNAs of LncRNAs and target genes
The sequences of lncRNAs were retrieved through NBCI Nucleotide (https://www.ncbi. nlm.nih.gov/nucleotide), which were then input into StarBase (http://starbase.sysu. edu.cn/), PITA (https://genie.weizmann.ac.il/pubs/mir07/mir07_data.html) and miRDB (http://www.mirdb.org/), to predict the target miRNAs of the lncRNAs. The miRNAs were input into TargetScan (http://www.targetscan.org/vert_71/), PicTar (http://pictar.mdcberlin.de/) and MiRanda (http://www.microrna.org/microrna/home.do) to predict the corresponding target genes.
Function of lncRNA target genes and pathway cluster analysis
The Database for Annotation, Visualization and Integrated Discovery (DAVID, http://david.abcc.ncifcrf.gov/) is an online program that provides a comprehensive set of functional annotation tools for researchers to understand biological meaning behind many genes. Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed for the identified DEGs using the DAVID database. After GO functional enrichment analysis, we considered the biology process terms with p-value <0.05 was statistically significant. For KEGG analysis, we considered the subpathway with p-value <0.05 was statistically significant.
RESULTS
Identifying differentially expressed lncRNAs
We re-annotated the GSE35864 and preliminarily retained 15,901 probes only with the ''NR_'' logo in the Refseq transcript ID. The Morpheus online tool was used to analyze and identify the differentially expressed probes with the ''NR_'' logo between the groups (Group A vs. Group D, Group B vs. Group D and Group C vs. Group D) of each region tissue (white matter, frontal cortex and basal ganglia brain tissues). As shown in Fig. 2A , there were differentially expressed probes with the ''NR_'' logo between different groups in the white matter, among which those that may be involved in the occurrence and development of HIVE were identified, and a total of 63 ncRNAs were identified. As shown in Fig. 2B , there were differentially expressed probes with the ''NR_'' logo between different groups in the frontal cortex, and the intersection was selected from each group. There was only 1 probe labeled with ''NR_'' intersected. As shown in Fig. 2C , there were differentially expressed probes with the ''NR_'' logo between different groups in the basal ganglia, and the intersection was selected from each group. There were 12 common probes labeled with ''NR_'' intersected. All the differential expressed ncRNAs with the ''NR_'' logo were searched in the GenBank, and 17 lncRNAs were identified in the white matter, without any differentially expressed lncRNAs in the frontal cortex and basal ganglia. These 17 lncRNAs were LINC00308, LOC100507387, SCOC-AS1, ALMS1-IT1, LINC00639, LOC101928847, LOC100134368, ZNF670-ZNF695, SHANK2-AS3, MEG9, SNHG7, TMEM44-AS1, LRRC8C-DT, MASP1, MAPT-AS1, TBX5-AS1, LINC01770. As shown in Fig. 3 , the expression of LINC00308, LOC100507387, SHANK2-AS3, SNHG7, MAPT-AS1 were significantly increasing in Group D, and the others were significantly decreasing. 
Prediction of target miRNAs of lncRNAs and target genes
The target micRNAs of the lncRNAs were identified from the database, and a total of 352 target miRNAs were predicted in 17 differentially expressed lncRNAs (Table 1 ). The 6,659 corresponding target genes of miRNAs were predicted by TargetScan, PicTar and MiRanda.
GO cluster analysis of target genes
The 6,659 target genes were uploaded to the DAVID software, and the significant GO classification and KEGG pathway were selected. GO cell component (CC) analysis showed that the target genes were obviously clustered in the nucleus, cytoplasm, Golgi apparatus, lysosome, plasma membrane, etc. (Fig. 4A , Table 2 ). GO molecular function (MF) analysis revealed that the target genes were remarkably clustered in transcription factor activity, protein serine/threonine kinase activity, transcription regulator activity, ubiquitin-specific protease activity, etc. (Fig. 4B , Table 2 ). GO biological process (BP) analysis revealed that the target genes were significantly clustered in regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism, signal transduction, cell communication, transport etc. (Fig. 4C , Table 2 ). Table 3 showed that 33 pathways were significantly enriched with target genes (p < 0.05), which were obtained through KEGG analysis, including mucin type O-Glycan biosynthesis, proteoglycans in cancer, pathways in cancer, glutamatergic synapse, long-term depression LOC100507387 hsa-miR-6876-5p; hsa-miR-4476; hsa-miR-6865-5p; hsa-miR-6815-5p; hsa-miR-6806-5p; hsa-miR-6739-5p; hsa-miR-6733-5p; hsa-miR-3153; hsa-miR-6878-3p; hsa-miR-4779; hsa-miR-8063; hsa-miR-4738-3p; hsa-miR-5584-5p; hsa-miR-4288; hsa-miR-3688-5p; hsa-miR-1206; hsa-miR-6797-5p; hsa-miR-3978; hsa-miR-1249-5p 3 NR_073536 SHANK2-AS3 hsa-miR-4447; hsa-miR-4713-3p; hsa-miR-516b-5p; hsa-miR-1229-3p; hsa-miR-6832-3p; hsa-miR-504-3p; hsa-miR-1275; hsa-miR-324-5p; hsamiR-6736-3p; hsa-miR-4443; hsa-miR-676-5p; hsa-miR-4483; hsa-miR-296-5p; hsa-miR-1224-3p; hsa-miR-96-5p; hsa-miR-1271-5p 4 NR_003672 /// NR_024542 /// NR_024543 SNHG7 hsa-miR-6887-5p; hsa-miR-6795-5p; hsa-miR-3201; hsa-miR-4793-5p; hsa-miR-6887-5p; hsa-miR-6795-5p; hsa-miR-3201; hsa-miR-4793-5p; hsa-miR-6836-5p; hsa-miR-6132; hsa-miR-5095; hsa-miR-4267; hsa-miR-6778-3p; hsa-miR-504-3p; hsa-miR-4262; hsa-miR-6890-5p; hsa-miR-425-5p; hsa-miR-378a-5p; hsa-miR-7151-3p 5 NR_024559 MAPT-AS1 hsa-miR-6772-5p; hsa-miR-4463; hsa-miR-511-5p; hsa-miR-3175; hsa-miR-532-5p; hsa-miR-4441; hsa-miR-340-5p; hsa-miR-223-5p; hsa-miR-6895-3p
KEGG pathway analysis of target genes
Downregulated lncRNAs 1 NR_033939 SCOC-AS1 hsa-miR-1205; hsa-miR-4508; hsa-miR-3194-5p; hsa-miR-4441; hsa-miR-6510-5p; hsa-miR-6836-5p; hsa-miR-6132; hsa-miR-4516; hsa-miR-135b-5p; hsa-miR-135a-5p; hsa-miR-3192-5p; hsa-miR-8081; hsa-miR-6876-5p; hsamiR-4756-5p; hsa-miR-4739; hsa-miR-1321; hsa-miR-3145-5p; hsa-miR-4427; hsa-miR-4748; hsa-miR-4464; hsa-miR-651-3p; hsa-miR-4524b-3p; hsa-miR-513a-5p; hsa-miR-6794-5p; hsa-miR-4716-3p; hsa-miR-3613-3p; hsa-miR-4668-5p; hsa-miR-6867-5p; hsa-miR-6753-5p; hsa-miR-450a-1-3p; hsa-miR-4752; hsa-miR-6794-3p; hsa-miR-3188; hsa-miR-937-5p; hsa-miR-6882-3p; hsa-miR-4328; hsa-miR-4476; hsa-miR-6727-5p; hsa-miR-5003-5p; hsa-miR-4268; hsa-miR-376c-5p; hsa-miR-376b-5p; hsa-miR-1252-5p; hsa-miR-608; hsa-miR-5581-3p; hsa-miR-4651; hsa-miR-4533 2 NR_046762 ALMS1-IT1 hsa-miR-4499; hsa-miR-888-5p; hsa-miR-616-5p; hsa-miR-373-5p; hsa-miR371b-5p; hsa-miR-1285-3p; hsa-miR-539-3p; hsa-miR-485-3p; hsa-miR-3685; hsa-miR-2052; hsa-miR-3143; hsa-miR-9-3p; hsa-miR-1303; hsa-miR-548c-3p; hsa-miR-6867-3p; hsa-miR-381-3p; hsa-miR-300; hsa-miR-4801; hsa-miR-4731-3p; hsa-miR-6515-3p; hsa-miR-7844-5p; hsa-miR-506-5p; hsa-miR-5680; hsa-miR-4297; hsa-miR-155-3p; hsa-miR-660-3p; hsa-miR-6847-3p; hsa-miR200a-3p; hsa-miR-141-3p; hsa-miR-6834-5p; hsa-miR-493-5p; hsa-miR-3911; hsa-miR-6073; hsa-miR-758-5p; hsa-miR-4426; hsa-miR-151a-3p; hsa-miR323a-3p; hsa-miR-939-3p; hsa-miR-4262; hsa-miR-181b-5p; hsa-miR-181a-5p; hsa-miR-3653-3p; hsa-miR-7108-5p; hsa-miR-4742-5p
(continued on next page) hsa-miR-6845-5p; hsa-miR-1227-5p; hsa-miR-1914-5p; hsa-miR-5088-3p; hsa-miR-6090; hsa-miR-631; hsa-miR-6762-5p; hsa-miR-4441; hsa-miR-3123; hsa-miR-6764-5p; hsa-miR-766-3p; hsa-miR-4690-5p; hsa-miR-532-3p; hsamiR-4297; hsa-miR-4456; hsa-miR-550b-2-5p; hsa-miR-4283; hsa-miR-4281; hsa-miR-4742-5p; hsa-miR-4311; hsa-miR-330-3p; hsa-miR-8089; hsa-miR-4700-5p; hsa-miR-4667-5p 4 NR_120563 LOC101928847 hsa-miR-645; hsa-miR-134-3p; hsa-miR-3651; hsa-miR-5089-3p; hsa-miR-4486; hsa-miR-890; hsa-miR-6512-5p; hsa-miR-6780b-5p; hsa-miR-4725-3p; hsa-miR-4271; hsa-miR-1296-3p; hsa-miR-653-5p; hsa-miR-302f; hsa-miR-491-5p; hsa-miR-6855-5p; hsa-miR-3170; hsa-miR-1236-3p; hsa-miR-93-3p; hsa-miR-663b; hsa-miR-4769-5p; hsa-miR-4654; hsa-miR-548aw; hsa-miR548d-5p; hsa-miR-548b-5p; hsa-miR-548ay-5p; hsa-miR-548aE−5p; hsa-miR548ad-5p; hsa-miR-548ab; hsa-miR-548c-3p; hsa-miR-1263; hsa-miR-6071; hsa-miR-5572; hsa-miR-4665-5p; hsa-miR-1275; hsa-miR-4478; hsa-miR-518c-5p; hsa-miR-3120-3p 5 NR_024453 LOC100134368 hsa-miR-6742-5p; hsa-miR-663a; hsa-miR-8060; hsa-miR-1827; hsa-miR-107; hsa-miR-103a-3p; hsa-miR-4441; hsa-miR-4456; hsa-miR-6134; hsa-miR-3911; hsa-miR-4478; hsa-miR-654-5p; hsa-miR-541-3p; hsa-miR-4764-5p; hsa-miR548x-5p; hsa-miR-548g-5p; hsa-miR-548f-5p; hsa-miR-548aj-5p; hsa-miR-4311; hsa-miR-3907; hsa-miR-4284; hsa-miR-744-5p; hsa-miR-6796-5p 6 NR_037894 ZNF670-ZNF695 hsa-miR-5584-5p; hsa-miR-6780a-5p; hsa-miR-4668-5p; hsa-miR-548t-3p; hsa-miR-548ap-3p; hsa-miR-548aa; hsa-miR-134-3p; hsa-miR-4306; hsa-miR-6764-5p; hsa-miR-1915-3p; hsa-miR-605-3p; hsa-miR-627-3p; hsa-miR-6779-5p; hsa-miR-3689c; hsa-miR-3689b-3p; hsa-miR-3689a-3p; hsa-miR-30b-3p; hsa-miR-1273h-5p; hsa-miR-4482-3p; hsa-miR-3128; hsa-miR-4497; hsa-miR-4297; hsa-miR-548z; hsa-miR-548h-3p; hsa-miR-548d-3p; hsa-miR-548bb-3p; hsa-miR-548ac; hsa-miR-3653-3p 7 NR_047664 MEG9 hsa-miR-4535; hsa-miR-4319; hsa-miR-7107-3p; hsa-miR-6753-3p; hsa-miR-4447; hsa-miR-6722-3p; hsa-miR-6069; hsa-miR-4426; hsa-miR-6721-5p; hsa-miR-7150; hsa-miR-1275; hsa-miR-7111-5p; hsa-miR-6870-5p; hsa-miR-5698; hsa-miR-4723-5p; hsa-miR-7-5p; hsa-miR-6165; hsa-miR-6502-5p; hsa-miR-1301-5p; hsa-miR-125b-5p; hsa-miR-125a-5p; hsa-miR-1226-5p; hsa-miR-4329; hsa-miR-4692; hsa-miR-4306; hsa-miR-4463; hsa-miR-4483; hsa-miR-205-3p; hsa-miR-8085; hsa-miR-6731-5p; hsa-miR-4283; hsa-miR-6794-5p; hsa-miR-4716-3p; hsa-miR-5010-5p; hsa-miR-4525; hsa-miR-4726-5p; hsa-miR-4640-5p
(continued on next page) TMEM44-AS1 hsa-miR-4468; hsa-miR-659-3p; hsa-miR-1304-5p; hsa-miR-4478; hsa-miR-4291; hsa-miR-661; hsa-miR-6801-5p; hsa-miR-6742-3p; hsa-miR-653-3p; hsa-miR-6813-5p; hsa-miR-6085; hsa-miR-3922-5p; hsa-miR-4650-5p; hsamiR-4717-5p; hsa-miR-3119; hsa-miR-597-3p; hsa-miR-7975; hsa-miR-296-5p; hsa-miR-2110; hsa-miR-4468; hsa-miR-659-3p; hsa-miR-1304-5p; hsa-miR-4478; hsa-miR-4291; hsa-miR-661; hsa-miR-653-3p; hsa-miR-6823-3p; hsamiR-2114-3p; hsa-miR-6801-5p; hsa-miR-6742-3p; hsa-miR-4261; hsa-miR-6813-5p; hsa-miR-6085; hsa-miR-3922-5p; hsa-miR-4650-5p; hsa-miR-4717-5p; hsa-miR-3119; hsa-miR-597-3p; hsa-miR-7975; hsa-miR-2110; hsa-miR-4468; hsa-miR-659-3p; hsa-miR-1304-5p; hsa-miR-4478; hsa-miR-4291; hsamiR-653-3p; hsa-miR-661; hsa-miR-6823-3p; hsa-miR-2114-3p; hsa-miR-6801-5p; hsa-miR-6742-3p; hsa-miR-4261; hsa-miR-6813-5p; hsa-miR-6085; hsamiR-3922-5p; hsa-miR-4650-5p; hsa-miR-4717-5p; hsa-miR-3119; hsa-miR-597-3p; hsa-miR-7975 9 NR_033981 LRRC8C-DT hsa-miR-3914; hsa-miR-194-3p; hsa-miR-937-3p; hsa-miR-608; hsa-miR-4651; hsa-miR-4707-5p; hsa-miR-1256; hsa-miR-561-5p; hsa-miR-4456; hsa-miR-1233-3p 10 NR_033519 MASP1 hsa-miR-4283; hsa-miR-6746-3p; hsa-miR-4441; hsa-miR-4763-5p; hsa-miR-1286; hsa-miR-5092; hsa-miR-4267; hsa-miR-4478; hsa-miR-1207-5p; hsa-miR-4531; hsa-miR-6768-3p; hsa-miR-4522; hsa-miR-6752-3p; hsa-miR-518c-5p; hsa-miR-6773-5p; hsa-miR-6724-5p; hsa-miR-6081; hsa-miR-6805-3p; hsamiR-5691; hsa-miR-6718-5p; hsa-miR-203b-5p; hsa-miR-4316; hsa-miR-1976; hsa-miR-3116; hsa-miR-1254; hsa-miR-376b-3p; hsa-miR-376a-3p 11 NR_038440 TBX5-AS1 hsa-miR-450b-5p; hsa-miR-4455; hsa-miR-765; hsa-miR-4532; hsa-miR-5192; hsa-miR-4428; hsa-miR-4419a; hsa-miR-296-5p; hsa-miR-6859-5p; hsa-miR-3916; hsa-miR-4263; hsa-miR-6802-3p; hsa-miR-3914; hsa-miR-933; hsa-miR-6805-5p; hsa-miR-129-5p; hsa-miR-1184; hsa-miR-6828-3p; hsa-miR-6129; hsa-miR-2115-3p; hsa-miR-4463; hsa-miR-4261; hsa-miR-3116; hsamiR-1254; hsa-miR-4516; hsa-miR-2110; hsa-miR-1273h-3p; hsa-miR-6125; hsa-miR-491-5p 12 NR_125994 /// NR_125995 /// NR_125996 LINC01770 hsa-miR-4723-5p; hsa-miR-7111-5p; hsa-miR-6870-5p; hsa-miR-5698; hsa-miR-1275; hsa-miR-4268; hsa-miR-4261; hsa-miR-4532; hsa-miR-604; hsa-miR-4723-5p; hsa-miR-7111-5p; hsa-miR-6870-5p; hsa-miR-5698; hsa-miR-1275; hsa-miR-4268; hsa-miR-4261; hsa-miR-4532; hsa-miR-604; hsa-miR-1227-5p; hsa-miR-4723-5p; hsa-miR-7111-5p; hsa-miR-6870-5p; hsa-miR-5698; hsa-miR-4447; hsa-miR-1275; hsa-miR-2861; hsa-miR-4268; hsa-miR-4267; hsa-miR-4261; hsa-miR-4532; hsa-miR-4707-5p; hsa-miR-6885-5p; hsa-miR-328-5p; hsa-miR-6811-3p; hsa-miR-604; hsa-miR-3620-3p 4.88E−07 CACNA1A HOMER1 KCNJ3 GNB5 GNG12 PRKCB GRIN2B GRM8 PLD1 ADCY4 GRIA4 CACNA1C SLC17A8 PLCB4 PLCB1 SLC38A2 MAPK1 JMJD7-PLA2G4B GRM7 GNAQ ADCY2 GLS PRKCA PRKACA GRIA1 HOMER2 GRIK4 GRM5 ADRBK1 PRKACB GNG2 GRM3 PPP3R1 ITPR1 PPP3CA GRM4 SLC17A6 GLS2 GRIA2 GRM6 GRIK3 GNAI1 SLC17A7 GRIN2A GNAI3 ADCY1 ITPR2 GNG11 ADCY5 SLC38A1 GRIA3 GRM2 PLD2 GRIK2 ADRBK2 SLC1A2 GRIN3A PLA2G4F PPP3CB DLGAP1 GNG13 TRPC1 GNAI2 GNAO1 Long-term depression 6.64E−07 CACNA1A RAF1 NRAS GRIA2 GUCY1A2 KRAS GNA12 GNAI1 BRAF PRKCB IGF1R GNAI3 NOS1 ITPR2 PPP2R1B PLCB4 PLCB1 MAPK1 JMJD7-PLA2G4B GNAQ GRIA3 GNA11 IGF1 PPP2CA PRKCA GRIA1 PRKG1 GUCY1B3 PLA2G4F PPP2R1A GUCY1A3 ITPR1 GNAI2 GNAO1 GRID2 CALM3 PLCE1 RASA2 GNB5 PAK6 PDGFA CSF1 JMJD7-PLA2G4B RALA IGF1 RASA4 SOS1  KSR1 PLA2G12A PRKACB PLA2G2C FGF2 GNG2 PDGFRB REL PIK3CB RAP1A RAPGEF5  FLT1 INSR VEGFA SOS2 RAF1 NGFR MAPK8 EGF GRIN2A IGF1R RASGRF2 PDGFD FGFR1  MET MRAS RASAL2 CSF1R RAB5B BCL2L1 FGF18 PLD2 RASGRP2 SYNGAP1 PDGFB GAB1  STK4 PLA2G4F RASA1 MAPK10 CALM1 FGFR2 FGF20 ETS1 ELK1 KRAS ABL2 GAB2 GNG12  CALM2 PRKCB GRIN2B FGF1 PIK3R1 PLD1 RALB CHUK PDGFRA AKT3 MAPK1 PGF  RHOA PAK7 PRKCA PRKACA FOXO4 HGF RAP1B RASSF1 EFNA3 PTPN11 NF1 FGF14  FGF5 KSR2 RASAL3 PAK2 NRAS FGF7 MAPK9 EGFR RAB5C FGF12 IKBKB PAK3 FGF23 TIAM1 GNG11 PIK3CA ANGPT2 PIK3R3 FGF9 FIGF GNG13 Oxytocin signaling pathway 0.000445043 CALM3 PPP1CC KCNJ2 ROCK1 KCNJ6 CACNA1C JMJD7-PLA2G4B NFATC3 GNAQ CAMK2A PRKAA2 KCNJ5 CAMKK1 PRKACB CAMK1G PIK3CB CACNG3 GUCY1A3 CAMK2B PRKAB2 CACNA2D1 RAF1 CACNG7 GNAI3 CAMK2D PPP1R12B ITPR2 ADCY5 PLA2G4F PPP3CB CALM1 CACNB4 CACNB1 GNAI2 CAMK1 PPP1CB KRAS ELK1 KCNJ3 CALM2 PRKCB PIK3R1 ADCY4 PLCB1 PLCB4 ROCK2 MAPK1 ADCY2 RHOA RYR2 PRKCA PRKACA MYLK4 NFATC1 CAMKK2 CAMK4 PRKAA1 CAMK2G PPP3R1 ITPR1 PPP3CA CAMK1D NRAS GUCY1A2 PRKAG1 NFATC2 CACNB3 CACNB2 GNAI1 EGFR ADCY1 CD38 Synaptic vesicle cycle 0.000719318 ATP6V1H CACNA1A SLC17A6 STX1B UNC13A CPLX3 VAMP2 UNC13C ATP6V1A ATP6V0E1 SLC17A7 CLTCL1 ATP6V0B STX2 SLC17A8 ATP6V0A1 SLC18A2 NAPA ATP6V0D2 CACNA1B ATP6V1C1 AP2M1 DNM3 ATP6V1B2 SYT1 ATP6V0D1 CLTC AP2B1 ATP6V1G2 AP2A1 ATP6V0A2 RIMS1 CPLX2 Glioma 0.000810759 RB1 CALM3 RAF1 SOS2 NRAS E2F3 KRAS MTOR BRAF CALM2 EGFR PRKCB PDGFA EGF PIK3R1 IGF1R CAMK2D PDGFRA AKT3 MAPK1 CAMK2A IGF1 SOS1 CCND1 PRKCA PIK3CA TP53 PTEN PDGFB CDK6 PDGFRB PIK3R3 PIK3CB TGFA CALM1 CAMK2G E2F2 CAMK2B ErbB signaling pathway 0.000950519 HBEGF ERBB4 ELK1 KRAS PTK2 ABL2 MTOR BRAF PRKCB PAK6 PIK3R1 GSK3B BTC AKT3 MAPK1 PAK7 CAMK2A SOS1 PRKCA CBLB STAT5B PIK3CB MAP2K4 TGFA CAMK2G CAMK2B SOS2 RAF1 NRAS PAK2 MAPK9 EGFR MAPK8 PAK3 EGF NRG4 CBL CAMK2D NRG3 NCK1 PIK3CA NRG1 CRK GAB1 RPS6KB1 PIK3R3 MAPK10 ERBB3 ERBB2 Choline metabolism in cancer 0.001052847 CHPT1 DGKA DGKG KRAS MTOR PRKCB PDGFA PCYT1B PIK3R1 SLC44A5 PLD1 PDGFRA PDPK1 AKT3 MAPK1 JMJD7-PLA2G4B WASL SOS1 HIF1A TSC1 PRKCA LYPLA1  PDGFRB PIK3CB DGKI DGKH SLC44A1 SOS2 RAF1 NRAS MAPK9 GPCPD1 EGFR MAPK8  DGKB EGF WASF2 DGKZ SP1 PDGFD SLC22A3 PCYT1A PLD2 PIK3CA DGKD PIP5K1B  PDGFB RPS6KB1 PIK3R3 PLA2G4F TSC2 WASF3 MAPK10 SLC44A3 SLC5A7 PIP5K1A  TGF-beta signaling pathway  0.001409773  BMPR2 INHBA ROCK1 ACVR2B BMPR1A PPP2R1B MAPK1 RHOA TGFB2 ID4 EP300  PPP2R1A SMAD3 SMAD4 TGFBR2 CHRD RBL1 SMAD2 SMAD5 GDF6 TGFBR1 SKP1  SP1 FST ACVR1 SMURF2 THBS1 ACVR1C CREBBP PPP2CA SMAD9 RPS6KB1 ZFYVE16  ACVR2A INHBB BMP2 INHBC SMURF1  Endocytosis  0.001595389  DNAJC6 SH3GL2 ERBB4 PRKCI ASAP2 CLTCL1 AGAP1 CHMP1B HLA-F TGFB2 PSD4 CBLB  AP2M1 DNM3 GIT1 ADRBK1 ADRB1 AP2A1 SH3GLB1 FLT1 TGFBR2 CYTH3 ASAP1 EHD4  ACAP2 ARAP2 SMAD2 PML EGF IQSEC3 IGF1R TFRC EPN2 MET DAB2 RUFY1 PSD2 F2R  SH3KBP1 SH3GL3 CSF1R RAB5B PARD3 TSG101 RNF41 PLD2 IQSEC1 RAB11A AGAP3  VTA1 RAB11FIP2 ARFGEF1 FGFR2 SMURF1 ITCH PIP5K1A RAB31 ARF5 ARF1 GIT2 SMAP2  STAM2 PLD1 PDGFRA EEA1 VPS36 STAMBP RABEP1 CCR5 RHOA EPN3 EPS15 WWP1  AGAP2 CLTC GRK1 ARF3 SMAD3 CHMP4B RAB22A RAB11FIP4 EHD2 ARFGEF2 CHMP7  PARD6G ZFYVE20 NEDD4 EGFR RAB5C CAV2 TGFBR1 CBL SMURF2 PSD3 SH3GLB2  CHMP2B RAB11FIP1 ARFGAP3 ADRBK2 PIP5K1B PDCD6IP AP2B1 ZFYVE16 VPS37D  ERBB3 ASAP3 ARRB1  cGMP-PKG signaling  pathway   0.001839639  CREB3L1 CALM3 PPP1CC PRKCE KCNMA1 ROCK1 ATP1A4 IRS2 CREB3L2 MEF2D  CACNA1C NFATC3 GNAQ PDE3A ADRB1 PIK3CB ATF2 GUCY1A3 BDKRB2 INSR VASP  RAF1 MEF2A ADRA2A PDE5A GNA12 EDNRA ATP2B2 GNAI3 ITPR2 IRS1 PDE2A ADCY5  GNA11 ATP2A2 PPP3CB KCNMB1 CALM1 GNAI2 PPP1CB CALM2 PIK3R1 ADCY4 AKT3  PLCB1 PLCB4 ROCK2 MAPK1 ADCY2 RHOA CREB3L3 MYLK4 NFATC1 SLC8A1 SRF  PRKG1 ATP2B4 PPP3R1 ITPR1 MRVI1 PPP3CA ATP2B1 GUCY1A2 NFATC2 GNAI1 ADCY1  PPP1R12A GTF2IRD1 CREB5 PIK3CA ATP1B2 MEF2C PIK3R3 GUCY1B3 ATP1B1 CREB1 (continued on next page) and other relevant pathways (Fig. 4D) . Eleven of these pathways may be related to the nervous system, including the glutamatergic synapse, axon guidance, Rap1 signaling pathway, Ras signaling pathway, synaptic vesicle cycle, ErbB signaling pathway, TGF-beta signaling pathway, cGMP-PKG signaling pathway, cholinergic synapse, Wnt signaling pathway and MAPK signaling pathway.
DISCUSSION
There are two main highlights in the research.
(1) The differentially expressed lncRNAs were identified through the re-annotation of published microarray results. (2) The target miRNAs of the lncRNAs and target genes were predicted using a bioinformatics method, and GO function and KEGG pathway analyses were performed to learn about the possible mechanisms of lncRNA involved in the occurrence and development of HIVE. In recent years, hundreds of lncRNAs have been discovered, and the changes in the expression of lncRNAs have been associated with the occurrence and development of many diseases. Plenty of evidence has shown that lncRNA is involved in the replication process of the virus (Zhang et al., 2013) and that lncRNA is involved in the infection process of HIV through changes in the cellular environment (Barichievy, Naidoo & Mhlanga, 2015) . However, the role of lncRNA in the occurrence and development of HIV-related encephalitis remains unclear. The mRNA, miRNA and lncRNA that were related to the diseases were identified by microarray and bioinformatic method, which has been applied in the study of many human diseases, just the same in the study of HIV-related encephalitis. Because the annotation of microarray results has been continuously updated, some new results may be obtained by the re-annotation and re-analysis of published chips in the common database. In the GEO public database, we retrieved more comprehensive microarray results of HIVE related study (multi-group and multi-organization types), and only differential analysis of the expression of mRNA in different brain tissues (the white matter, frontal cortex and basal ganglia brain tissues) of each group was carried out. We re-annotated the microarray results and identified possible ncRNA probe results to construct the ncRNA microarray results. In addition, we then compared and analyzed the results to identiry differentially expressed ncRNAs that may be involved in the occurrence and development of HIVE. We identified 63 probes with the ''NR_'' logo in the white matter, one probe with the ''NR_'' logo in the frontal cortex, and 12 probes with the ''NR_'' logo in basal ganglia. All the probes with the ''NR_'' logo were retrieved, and it was found that only 17 probes with the ''NR_'' logo in the white matter were identified as lncRNAs. Among these 17 lncRNAs, expression of five were increasing in Group D, and the others were decreasing. As we found differentially expressed lncRNAs only in white matter, we speculated that cerebral white matter lesions may play an important role in the pathogenesis of HIV-associated encephalitis, which was also consistent with previous research results. The central nervous system injury affected by HIV-1 usually manifested microglial nodules comprised of multinucleated giant cells and inflammatory cells. These lesions are particularly in white matter (Fischer-Smith et al., 2001 ) Neuronal damage in HIVE is generally attributed to fully activated microglia/macrophages, especially in white matter (Roberts, Masliah & Fox, 2004) . In addition, multinucleated giant cells and perivascular demyelination leading to white matter pallor are typical features of HIVE. In addition, these lncRNAs could be used as markers of white matter damage of HIVE. Based on the lncRNA-miRNA-mRNA mechanism,we used bioinformatics tools to predict target miRNAs and target genes of these 17 lncRNAs. GO and KEGG analysis were carried out to make the correlation cluster analysis on target genes, in order to explore the potential mechanisms of lncRNAs participating in HIVE. The GO cell component (CC) analysis results revealed that the target genes were significantly clustered in the nucleus, cytoplasm, Golgi apparatus, lysosome, plasma membrane, etc. The GO molecular function (MF) analysis showed that the target genes were significantly clustered in the transcription factor activity, protein serine/threonine kinase activity, transcription regulator activity, ubiquitin-specific protease activity and other molecular functions. The GO biological process (BP) analysis revealed that the target genes were significantly clustered in the regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolism, signal transduction, cell communication, transport and other biological processes. Therefore, it was proven that lncRNAs may be involved in the occurrence and development of HIVE by way of their participation in the process of nuclear transcription and translation. The KEGG pathway analysis showed the target genes were significantly clustered in the mucin type O-glycan biosynthesis, proteoglycans in cancer, pathways in cancer, the glutamatergic synapse, long-term depression and other relevant pathways. In previous research, it was found that a variety of pathways were involved in neurological disorders and even in the occurrence of HIVE. The pathway of glutamatergic synapse was related with the occurrence of encephalitis, and the patients with anti-NMDAR encephalitis had a diminished function of the glutamatergic synapse (Hughes et al., 2010) . The expression changes of the glutamatergic synapse in the brain tissues were associated with the occurrence of hepatic encephalopathy (Montana, Verkhratsky & Parpura, 2014) . For the axon guidance pathway, it has been reported of relevant gene expression impairment of the axon guidance pathway and its downstream pathway (including MAPK pathway, calcium signaling pathway, Jak-STAT signaling pathway and VEGF signaling pathway) in the brain tissues of the patients with HIV-associated dementia, which provided new ideas for the diagnosis and treatment of HIV-associated dementia (Zhou et al., 2012) . Both Rap1 signaling pathway and Ras signaling pathway were involved in such nervous system functions as glutamatergic synaptic transmission (Imamura et al., 2003) , synaptic excitability (Imamura et al., 2004) , synaptic reversibility (Masliah et al., 2004) , etc. The abnormal expression of signaling pathway can cause encephalitis and other neuronal dysfunctions. The changes in the synaptic vesicle, especially the synaptic vesicle cycle, can cause abnormal neurotransmitter activity (Cortes-Saladelafont et al., 2016) . For the ErbB signaling pathway, there were significant changes in the gene expression of ErbB signaling pathway in the brain tissues of the patients with HIV-associated dementia (Shityakov, Dandekar & Forster, 2015) . The TGF-β signaling pathway was also involved in the pathophysiology of the nervous system, which can limit inflammation and reduce neurological damage in the nervous system infection process (Cekanaviciute et al., 2014) . The TGF-β signaling pathway was also related with the tolerance of dendritic cells (Esebanmen & Langridge, 2017) . Together with the STAT2 signaling pathway, the TGF-β signaling pathway can inhibit the progression of autoimMune encephalopathy (Xu et al., 2014) . For the cGMP-PKG signaling pathway, its abnormality had something to do with the diseases of the nervous system, and reduced kinase activity in the cGMP-PKG signaling pathway was found in rats with hepatic encephalopathy. Cognitive disorders could be relieved when the NO/sGC/cGMP/PKG signaling pathway was inhibited in diabetic rats. The iNOS-NO-cGMP signaling pathway also was involved in nervous system inflammation and myelin formation (Raposo et al., 2014) . The activation of the Wnt signaling pathway could promote the occurrence of autoimMune encephalitis (Schneider et al., 2016) , and the Wnt signaling pathway was involved in the immunity and tolerance of dendritic cells (Swafford & Manicassamy, 2015) . Moreover, plasma Dickkopf-related protein 1, the antagonist of the Wnt signaling pathway, was associated with HIV-related cognitive deficits (Yu et al., 2017) . Therefore, KEGG analysis showed that most of the significant clustering pathways were related with the function of the nervous system. Thus, the differentially expressed lncRNAs, act as ''molecular sponges'', could affect the function of their target miRNAs, and thereby regulating target genes. It can be confirmed that lncRNA is indeed involved in the occurrence and development of HIV-related encephalopathy through the lncRNA-miRNA-gene mechanism. In addition, it could also be indirectly confirmed that it is feasible to construct a new chips by re-annotation and identify differentially expressed lncRNA from a expression chip.
CONCLUSIONS
The brand-new microarray results from a different perspective can be constructed through the updated annotation of the precious and published microarray data. In this study, the lncRNA results were obtained through the re-annotation of microarray data, which provides the foundation for further research on the role of lncRNA in the occurrence and development of HIVE. From the point of view of the lncRNA-miRNA-target genes, cluster analysis was performed by various bioinformatic methods to explore the role of lncRNA. GO analysis showed that lncRNA may be involved in the occurrence and development of HIVE via its participation in the nuclear transcription and translation. The KEGG pathway analysis showed that most of the KEGG pathways with statistical significance were associated with the function of the nervous system. Therefore, we can speculate that lncRNA is indeed involved in the occurrence and development of HIVE, which is of great significance for future research on lncRNA on HIVE. It is also proved that it is feasible to identify lncRNAs from public database.
